why choose us

First received: October 23, 2023

Clinical Trial: "Pulmonary Rehabilitation Program in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis"

Study Status: Completed

Recruit Status: RECRUITING

Condition: Systemic Sclerosis Associated Interstitial Lung Disease

Study Type: OBSERVATIONAL


Official Title: "Effect of a Pulmonary Rehabilitation Program in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis on Oxygen Consumption, Functionality, and Quality of Life"

Brief Summary: Interstitial Lung Disease associated with Systemic Sclerosis currently represents the main cause of death in this disease, it is also the cause of significant morbidity, which is why pulmonary rehabilitation strategies can be of great benefit in this group of patients.The aim of this study is to determine the effect of a 36-session supervised pulmonary rehabilitation program compared before and after, on oxygen consumption, functionality, and quality of life in Interstitial LungThe main question it aims to answer…

Read more